Allergan creates 63 jobs with biologics manufacturing expansion in Ireland
Allergan will expand its existing facilities in Ireland through an investment of €65m to produce new product formats for existing and investigational products.
Allergan will expand its existing facilities in Ireland through an investment of €65m to produce new product formats for existing and investigational products.
Kite adds a facility in Maryland to expand manufacturing capabilities of its CAR-T therapies, including Yescarta.